414 related articles for article (PubMed ID: 17063773)
1. Susceptibility to 5-fluorocytosine, miconazole and amphotericin B of Candida albicans strains isolated from the throat of non-AIDS patients.
Paniagua GL; Monroy E; Negrete E; Vaca S
Rev Latinoam Microbiol; 2002; 44(2):65-8. PubMed ID: 17063773
[TBL] [Abstract][Full Text] [Related]
2. The influence of antifungal drugs on adherence of Candida albicans to buccal epithelial cells.
Brenciaglia MI; Ghezzi MC; Cipriani P; Mancini C; Trancassini M
Chemioterapia; 1986 Jun; 5(3):200-3. PubMed ID: 3521918
[TBL] [Abstract][Full Text] [Related]
3. [Comparative sensitivity of yeasts to antifungal agents using a standardized micromethod].
Guinet R
Pathol Biol (Paris); 1986 May; 34(5):536-9. PubMed ID: 3534739
[TBL] [Abstract][Full Text] [Related]
4. [Susceptibility to miconazole and itraconazole of Candida strains isolated from hospitalized and outpatient clinic patients].
Kurnatowska AK; Kwaśniewska J
Wiad Parazytol; 2009; 55(4):415-23. PubMed ID: 20209818
[TBL] [Abstract][Full Text] [Related]
5. [Comparative study of two systems for the determination of the sensitivity of yeasts to antifungal agents].
de Montclos M; de Montclos H; Flandrois JP
Pathol Biol (Paris); 1992 May; 40(5):495-9. PubMed ID: 1495833
[TBL] [Abstract][Full Text] [Related]
6. [Antifungal susceptibility of clinically isolated Candida albicans by broth microdilution method].
Yamazumi T; Kuroda T; Ohata T; Obana Y; Furuta I
Kansenshogaku Zasshi; 1998 Aug; 72(8):813-9. PubMed ID: 9780584
[TBL] [Abstract][Full Text] [Related]
7. [In vitro comparative study of the sensitivity of Aspergillus to antifungal agents].
Guinet R; Mazoyer MA
Pathol Biol (Paris); 1984 Jun; 32(5 Pt 2):654-7. PubMed ID: 6462761
[TBL] [Abstract][Full Text] [Related]
8. Combined effects of hyperbaric oxygen and antifungal agents on the growth of Candida albicans.
Gudewicz TM; Mader JT; Davis CP
Aviat Space Environ Med; 1987 Jul; 58(7):673-8. PubMed ID: 3304267
[TBL] [Abstract][Full Text] [Related]
9. [Short communication: In vitro activity of amphotericin B with fluconazole or voriconazole combinations against Candida albicans isolates].
Oz Y; Akşit F; Kiraz N; Kiremitçi A
Mikrobiyol Bul; 2008 Jan; 42(1):149-55. PubMed ID: 18444574
[TBL] [Abstract][Full Text] [Related]
10. Survey of amphotericin B susceptibility of Candida clinical isolates determined by Etest.
Chiu YS; Chang SC; Hsueh PR; Wang JL; Sun HY; Chen YC
J Microbiol Immunol Infect; 2006 Aug; 39(4):335-41. PubMed ID: 16926981
[TBL] [Abstract][Full Text] [Related]
11. [The comparison of susceptibility of Candida albicans and Candida glabrata to miconazole].
Kurnatowski P; Makieło L; Horwatt-Bozyczko E
Wiad Parazytol; 2001; 47(4):867-73. PubMed ID: 16886440
[TBL] [Abstract][Full Text] [Related]
12. [In vitro sensitivity to 5-fluorocytosine and amphotericin B of yeasts of the Candida genus isolated in Barcelona].
Torres-Rodríguez JM; Sabaté M; Gallach C; Carrillo A; Madrenys N
Enferm Infecc Microbiol Clin; 1990 Feb; 8(2):91-3. PubMed ID: 2098147
[TBL] [Abstract][Full Text] [Related]
13. [Sensitivity of clinical isolates of Candida albicans to 5-fluorocytosine].
Fernández Andreu CM; Lemus Molina D; Martínez Machín G
Rev Cubana Med Trop; 2000; 52(3):191-6. PubMed ID: 11826522
[TBL] [Abstract][Full Text] [Related]
14. Sensitivity of yeasts to amphotericin B and 5-fluorocytosine.
Abdul-Samad S; Arumugham G; Yasin MS
Malays J Pathol; 1989 Aug; 11():37-42. PubMed ID: 2632999
[TBL] [Abstract][Full Text] [Related]
15. [Identification and susceptibility of clinically isolated yeast-like fungi].
Fukuchi K; Tanaka Y; Oguro T; Wakuta R; Sugita M; Takagi Y; Gomi K
Rinsho Byori; 1990 Aug; 38(8):931-6. PubMed ID: 2232256
[TBL] [Abstract][Full Text] [Related]
16. Correlation of in vitro and in vivo susceptibility of Candida albicans to amphotericin B and natamycin.
O'Day DM; Ray WA; Robinson RD; Head WS
Invest Ophthalmol Vis Sci; 1987 Mar; 28(3):596-603. PubMed ID: 3549613
[TBL] [Abstract][Full Text] [Related]
17. [Investigation of quantitative and species composition and antifungal drug susceptibility of yeasts isolated from patients with generalized periodontitis complicated by candidosis].
Kutsyk RV; Pavliuk TD
Mikrobiol Z; 2003; 65(5):26-9. PubMed ID: 14723159
[TBL] [Abstract][Full Text] [Related]
18. In vitro susceptibilities of sucrose-negative Candida tropicalis, Candida lusitaniae, and Candida norvegensis to amphotericin B, 5-fluorocytosine, miconazole, and ketoconazole.
Ahearn DG; McGlohn MS
J Clin Microbiol; 1984 Mar; 19(3):412-6. PubMed ID: 6325491
[TBL] [Abstract][Full Text] [Related]
19. Antifungal susceptibility of epigallocatechin 3-O-gallate (EGCg) on clinical isolates of pathogenic yeasts.
Park BJ; Park JC; Taguchi H; Fukushima K; Hyon SH; Takatori K
Biochem Biophys Res Commun; 2006 Aug; 347(2):401-5. PubMed ID: 16831406
[TBL] [Abstract][Full Text] [Related]
20. In vitro susceptibility of Candida albicans isolates from apical and marginal periodontitis to common antifungal agents.
Waltimo TM; Ørstavik D; Meurman JH; Samaranayake LP; Haapasalo MP
Oral Microbiol Immunol; 2000 Aug; 15(4):245-8. PubMed ID: 11154410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
